Skip to main content

NASDAQ:HQY - HealthEquity Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $82.78
  • Forecasted Upside: 11.07 %
  • Number of Analysts: 10
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 6 Buy Ratings
  • 1 Strong Buy Ratings
$74.53
▲ +1.41 (1.93%)
1 month | 3 months | 12 months
Get New HealthEquity Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HQY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HQY

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$82.78
▲ +11.07% Upside Potential
This price target is based on 10 analysts offering 12 month price targets for HealthEquity in the last 3 months. The average price target is $82.78, with a high forecast of $92.00 and a low forecast of $70.00. The average price target represents a 11.07% upside from the last price of $74.53.

Buy

The current consensus among 10 contributing investment analysts is to buy stock in HealthEquity. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 1 strong buy ratings
  • 11 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/14/2019
  • 1 strong buy ratings
  • 10 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/12/2020
  • 1 strong buy ratings
  • 10 buy ratings
  • 4 hold ratings
  • 0 sell ratings
5/12/2020
  • 1 strong buy ratings
  • 8 buy ratings
  • 4 hold ratings
  • 0 sell ratings
8/10/2020
  • 1 strong buy ratings
  • 7 buy ratings
  • 3 hold ratings
  • 0 sell ratings
11/8/2020
  • 1 strong buy ratings
  • 8 buy ratings
  • 4 hold ratings
  • 0 sell ratings
2/6/2021
  • 1 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 0 sell ratings
4/7/2021
  • 1 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 0 sell ratings
5/7/2021

Latest Recommendations

  • 1 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/29/2021JPMorgan Chase & Co.Initiated CoverageOverweightLow
i
3/29/2021Raymond JamesLower Price TargetStrong-Buy$100.00 ➝ $85.00High
i
3/23/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$88.00 ➝ $92.00N/A
i
3/22/2021SVB LeerinkBoost Price TargetMarket Perform$77.00 ➝ $80.00N/A
i
3/22/2021Raymond JamesLower Price TargetStrong-Buy$100.00 ➝ $85.00Low
i
3/17/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$88.00 ➝ $92.00Medium
i
3/16/2021SVB LeerinkBoost Price TargetMarket Perform$77.00 ➝ $80.00High
i
2/10/2021Raymond JamesBoost Price TargetStrong-Buy$75.00 ➝ $100.00Low
i
2/9/2021Barrington ResearchReiterated RatingOutperform$75.00 ➝ $90.00Low
i
2/9/2021Truist FinancialBoost Price Target$80.00 ➝ $92.00Low
i
2/9/2021Royal Bank of CanadaBoost Price TargetOutperform$74.00 ➝ $87.00Low
i
1/6/2021BTIG ResearchInitiated CoverageNeutralN/A
i
1/6/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$60.00 ➝ $77.00N/A
i
12/8/2020Cantor FitzgeraldBoost Price TargetOverweight$70.00 ➝ $77.00High
i
Rating by S. Halper at Cantor Fitzgerald
12/8/2020JPMorgan Chase & Co.Boost Price TargetOverweight$61.00 ➝ $72.00High
i
12/8/2020Barrington ResearchBoost Price TargetOutperform$70.00 ➝ $75.00Low
i
12/8/2020Royal Bank of CanadaBoost Price TargetOutperform$67.00 ➝ $74.00Medium
i
12/2/2020SVB LeerinkBoost Price TargetMarket Perform$64.00 ➝ $77.00High
i
11/23/2020GuggenheimDowngradeBuy ➝ NeutralMedium
i
10/23/2020Royal Bank of CanadaInitiated CoverageOutperform$67.00High
i
9/10/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$57.00 ➝ $60.00High
i
9/9/2020Barrington ResearchBoost Price TargetOutperform$65.00 ➝ $70.00Low
i
Rating by Alexander Paris at Barrington Research
9/9/2020Wells Fargo & CompanyBoost Price TargetOverweight$63.00 ➝ $70.00High
i
9/9/2020SVB LeerinkBoost Price TargetPositive ➝ Market Perform$51.00 ➝ $64.00High
i
Rating by S. Demko at SVB Leerink LLC
9/9/2020Raymond JamesReiterated RatingBuyHigh
i
6/3/2020Cantor FitzgeraldLower Price TargetOverweight$80.00 ➝ $70.00Low
i
Rating by Steven Halper at Cantor Fitzgerald
6/1/2020Barrington ResearchReiterated RatingBuy$65.00Low
i
Rating by Alexander Paris at Barrington Research
4/20/2020Cantor FitzgeraldReiterated RatingBuy$80.00High
i
Rating by Steven Halper at Cantor Fitzgerald
4/14/2020GuggenheimInitiated CoverageBuy$56.00Medium
i
4/13/2020SVB LeerinkInitiated CoverageMarket Perform$53.00Medium
i
Rating by S. Demko at SVB Leerink LLC
4/8/2020Raymond JamesLower Price TargetStrong-Buy$90.00 ➝ $75.00High
i
3/27/2020Raymond JamesLower Price TargetReduce ➝ Strong-Buy$110.00 ➝ $90.00High
i
3/26/2020SunTrust BanksBoost Price TargetBuy$55.00 ➝ $68.00Medium
i
3/18/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$88.00 ➝ $57.00Low
i
3/17/2020Barrington ResearchLower Price TargetOutperform$86.00 ➝ $65.00High
i
Rating by Alexander Paris at Barrington Research
3/17/2020SunTrust BanksLower Price TargetBuy$87.00 ➝ $55.00High
i
3/17/2020Robert W. BairdLower Price TargetNeutral$74.00 ➝ $47.00High
i
3/17/2020KeyCorpLower Price TargetOverweight$86.00 ➝ $65.00High
i
Rating by Donald Hooker at KeyCorp
3/17/2020Cantor FitzgeraldReiterated RatingOverweight$90.00 ➝ $80.00High
i
Rating by Steven Halper at Cantor Fitzgerald
2/20/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$74.00 ➝ $88.00Low
i
2/19/2020Barrington ResearchReiterated RatingBuy$86.00High
i
Rating by Alexander Paris at Barrington Research
2/19/2020Wells Fargo & CompanyBoost Price TargetOverweight$80.00 ➝ $87.00High
i
2/19/2020KeyCorpBoost Price TargetOverweight$80.00 ➝ $86.00High
i
Rating by Donald Hooker at KeyCorp
1/8/2020Wells Fargo & CompanyBoost Price TargetOverweight$76.00 ➝ $80.00Medium
i
12/4/2019Cantor FitzgeraldReiterated RatingBuy$95.00High
i
Rating by Steven Halper at Cantor Fitzgerald
12/4/2019KeyCorpReiterated RatingBuy$70.00 ➝ $77.00High
i
Rating by Donald Hooker at KeyCorp
12/2/2019Barrington ResearchReiterated RatingBuy$75.00High
i
Rating by Alexander Paris at Barrington Research
10/7/2019The Goldman Sachs GroupInitiated CoverageNeutral$56.00 ➝ $56.00Medium
i
9/30/2019KeyCorpSet Price TargetBuy$70.00High
i
Rating by Donald Hooker at KeyCorp
9/17/2019KeyCorpLower Price TargetOverweight$90.00 ➝ $70.00Low
i
9/12/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy$74.00Low
i
9/9/2019SunTrust BanksLower Price TargetBuy$80.00Medium
i
9/9/2019Raymond JamesUpgradeOutperform ➝ Strong-Buy$90.00 ➝ $80.00Medium
i
Rating by Charles Peters at Raymond James
9/4/2019Bank of AmericaSet Price TargetBuy$79.00Low
i
Rating by Allen Lutz at Bank of America Co.
9/4/2019Barrington ResearchReiterated RatingOutperform$100.00 ➝ $75.00High
i
9/4/2019OppenheimerLower Price TargetOutperform$98.00 ➝ $76.00High
i
9/4/2019Wells Fargo & CompanyLower Price TargetOutperformer$80.00 ➝ $76.00High
i
7/19/2019Raymond JamesBoost Price TargetOutperform$85.00 ➝ $90.00Medium
i
7/19/2019Bank of AmericaUpgradeNeutral ➝ Buy$75.00 ➝ $90.00High
i
Rating by Allen Lutz at Bank of America Co.
6/28/2019CitigroupReiterated RatingBuyMedium
i
Rating by Stephanie Davis at Citigroup Inc.
6/10/2019Raymond JamesBoost Price TargetOutperform$80.00 ➝ $85.00Low
i
6/5/2019Bank of AmericaReiterated RatingNeutral ➝ Neutral$83.00 ➝ $75.00High
i
Rating by Allen Lutz at Bank of America Co.
6/5/2019JPMorgan Chase & Co.Set Price TargetOverweight$91.00 ➝ $80.00High
i
5/10/2019CitigroupReiterated RatingBuyMedium
i
Rating by Stephanie Davis at Citigroup Inc.
3/19/2019OppenheimerBoost Price TargetOutperform$74.00 ➝ $98.00Medium
i
3/19/2019Bank of AmericaBoost Price TargetNeutral ➝ Neutral$82.00 ➝ $83.00High
i
Rating by Allen Lutz at Bank of America Co.
3/19/2019KeyCorpBoost Price TargetOverweight ➝ Overweight$74.00 ➝ $90.00High
i
3/19/2019Cantor FitzgeraldBoost Price TargetOverweight$83.00 ➝ $90.00High
i
3/1/2019Bank of AmericaReiterated RatingNeutral ➝ Neutral$67.00 ➝ $82.00Medium
i
Rating by Allen Lutz at Bank of America Co.
2/7/2019Cantor FitzgeraldBoost Price TargetOverweight$80.00 ➝ $83.00High
i
2/7/2019Chardan CapitalReiterated RatingBuy ➝ Buy$82.00 ➝ $78.00High
i
2/7/2019SunTrust BanksUpgradeHold ➝ Buy$81.00High
i
1/8/2019CitigroupSet Price TargetBuy$102.00Medium
i
Rating by Stephanie Davis at Citigroup Inc.
12/17/2018Cantor FitzgeraldUpgradeNeutral ➝ Overweight$82.00High
i
12/7/2018Wells Fargo & CompanyLower Price TargetOutperform ➝ Outperform$100.00 ➝ $90.00High
i
12/6/2018Cantor FitzgeraldBoost Price TargetNeutral ➝ Neutral$80.00 ➝ $82.00High
i
12/6/2018SunTrust BanksDowngradeBuy ➝ Hold$105.00 ➝ $90.00High
i
9/10/2018Raymond JamesBoost Price TargetOutperform ➝ Outperform$85.00 ➝ $105.00Low
i
9/6/2018Bank of AmericaDowngradeBuy ➝ Neutral$84.00 ➝ $105.00Low
i
Rating by Allen Lutz at Bank of America Co.
9/5/2018Barrington ResearchReiterated RatingOutperform$100.00Medium
i
9/5/2018SunTrust BanksBoost Price TargetBuy$105.00Medium
i
9/5/2018OppenheimerBoost Price TargetOutperform$85.00 ➝ $104.00High
i
9/5/2018Cantor FitzgeraldBoost Price TargetNeutral ➝ Neutral$68.00 ➝ $80.00High
i
9/5/2018Wells Fargo & CompanyBoost Price TargetOutperform ➝ Outperform$84.00 ➝ $105.00High
i
9/5/2018CitigroupReiterated RatingBuy$110.00High
i
9/4/2018KeyCorpBoost Price TargetOverweight ➝ Overweight$90.00 ➝ $105.00Low
i
7/19/2018KeyCorpBoost Price TargetBuy$82.00 ➝ $90.00Low
i
6/5/2018Barrington ResearchBoost Price TargetOutperform$85.00High
i
6/5/2018OppenheimerBoost Price TargetOutperform$68.00 ➝ $85.00Low
i
6/5/2018Robert W. BairdBoost Price TargetNeutral ➝ Neutral$61.00 ➝ $77.00Low
i
6/5/2018SunTrust BanksBoost Price TargetBuy$70.00 ➝ $85.00Low
i
6/5/2018KeyCorpBoost Price TargetOverweight ➝ Overweight$72.00 ➝ $82.00Low
i
6/4/2018Cantor FitzgeraldReiterated RatingNeutral ➝ Hold$65.00 ➝ $68.00Low
i
5/30/2018Cantor FitzgeraldDowngradeOverweight ➝ Neutral$65.00High
i
5/23/2018Bank of AmericaInitiated CoverageBuy$83.00Medium
i
4/24/2018JPMorgan Chase & Co.Initiated CoverageOverweight ➝ Overweight$60.00 ➝ $69.00Low
i
Rating by Anne McCormick at JPMorgan Chase & Co.
4/5/2018KeyCorpBoost Price TargetOverweight ➝ Overweight$66.00 ➝ $72.00Low
i
3/23/2018Cantor FitzgeraldReiterated RatingBuy$65.00Low
i
3/20/2018Barrington ResearchBoost Price TargetOutperform$65.00High
i
3/20/2018OppenheimerBoost Price TargetOutperform ➝ Outperform$58.00 ➝ $68.00High
i
3/20/2018KeyCorpBoost Price TargetOverweight ➝ Overweight$62.00 ➝ $66.00High
i
3/20/2018Chardan CapitalBoost Price TargetBuy ➝ Buy$62.00 ➝ $77.00High
i
3/20/2018Robert W. BairdBoost Price TargetNeutral ➝ Neutral$49.00 ➝ $61.00High
i
3/20/2018CitigroupBoost Price TargetOutperform$58.00 ➝ $68.00High
i
3/20/2018SunTrust BanksBoost Price TargetPositive ➝ Buy$70.00High
i
2/22/2018Cantor FitzgeraldReiterated RatingBuy$60.00High
i
2/7/2018Cantor FitzgeraldBoost Price TargetOverweight ➝ Overweight$56.00 ➝ $60.00Medium
i
2/7/2018Robert W. BairdBoost Price TargetNeutral ➝ Neutral$48.00 ➝ $49.00Medium
i
1/24/2018JPMorgan Chase & Co.Lower Price TargetOverweight ➝ Overweight$52.00 ➝ $51.00Low
i
1/4/2018CitigroupInitiated CoverageBuyMedium
i
12/6/2017Chardan CapitalBoost Price TargetBuy ➝ Buy$58.00 ➝ $62.00High
i
12/5/2017Cantor FitzgeraldReiterated RatingBuy$56.00Low
i
9/25/2017Cantor FitzgeraldReiterated RatingBuy$56.00Low
i
9/21/2017Robert W. BairdReiterated RatingNeutral ➝ HoldMedium
i
9/6/2017OppenheimerReiterated RatingBuy$61.00Low
i
9/5/2017Cantor FitzgeraldReiterated RatingBuy$56.00Low
i
8/29/2017Cantor FitzgeraldReiterated RatingBuy$56.00Medium
i
7/5/2017Cantor FitzgeraldBoost Price TargetOverweight$55.00 ➝ $56.00Medium
i
6/12/2017OppenheimerReiterated RatingOutperform$57.00 ➝ $61.00Low
i
6/7/2017Cantor FitzgeraldBoost Price TargetOverweight$50.00 ➝ $55.00High
i
6/7/2017Chardan CapitalBoost Price TargetBuy ➝ Buy$53.00 ➝ $57.00High
i
3/30/2017Cantor FitzgeraldInitiated CoverageOverweight ➝ Overweight$50.00High
i
3/22/2017JPMorgan Chase & Co.Boost Price TargetOverweight$44.00 ➝ $51.00High
i
3/22/2017Chardan CapitalReiterated RatingBuy ➝ Buy$50.00 ➝ $53.00High
i
3/14/2017CIBCInitiated CoverageOutperform ➝ OutperformMedium
i
3/14/2017FIXInitiated CoverageOutperformMedium
i
3/14/2017Wells Fargo & CompanyInitiated CoverageOutperformMedium
i
3/13/2017OppenheimerInitiated CoverageOutperform$58.00Medium
i
2/13/2017Chardan CapitalReiterated RatingBuyN/A
i
2/7/2017Chardan CapitalReiterated RatingBuy ➝ Buy$47.00N/A
i
1/23/2017KeyCorpInitiated CoverageOverweight$60.00N/A
i
12/13/2016Chardan CapitalInitiated CoverageBuy$50.00N/A
i
10/28/2016JPMorgan Chase & Co.Initiated CoverageOverweight$43.00N/A
i
9/12/2016Raymond JamesBoost Price TargetOutperform$32.00 ➝ $40.00N/A
i
9/8/2016SunTrust BanksReiterated RatingBuyN/A
i
9/8/2016Barrington ResearchBoost Price TargetOutperform$34.00 ➝ $38.00N/A
i
9/7/2016Robert W. BairdBoost Price TargetNeutral$31.00 ➝ $35.00N/A
i
6/22/2016Wells Fargo & CompanyReiterated RatingBuyN/A
i
6/8/2016SVB LeerinkReiterated RatingOutperform$30.00 ➝ $33.00N/A
i
6/8/2016Wells Fargo & CompanyReiterated RatingBuyN/A
i
6/8/2016SunTrust BanksBoost Price TargetBuy$34.00 ➝ $40.00N/A
i
(Data available from 5/8/2016 forward)
HealthEquity logo
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is headquartered in Draper, Utah.
Read More

Today's Range

Now: $74.53
$72.82
$75.00

50 Day Range

MA: $71.11
$66.24
$77.42

52 Week Range

Now: $74.53
$45.82
$93.32

Volume

179,249 shs

Average Volume

808,791 shs

Market Capitalization

$6.19 billion

P/E Ratio

1,490.90

Dividend Yield

N/A

Beta

1.56

Frequently Asked Questions

What sell-side analysts currently cover shares of HealthEquity?

The following equities research analysts have issued reports on HealthEquity in the last twelve months: Barrington Research, BTIG Research, Cantor Fitzgerald, Deutsche Bank Aktiengesellschaft, Guggenheim, JPMorgan Chase & Co., Raymond James, Royal Bank of Canada, SVB Leerink LLC, Truist Financial Co., Wells Fargo & Company, and Zacks Investment Research.
View the latest analyst ratings for HQY.

What is the current price target for HealthEquity?

9 Wall Street analysts have set twelve-month price targets for HealthEquity in the last year. Their average twelve-month price target is $82.78, suggesting a possible upside of 11.1%. Truist Financial Co. has the highest price target set, predicting HQY will reach $92.00 in the next twelve months. Wells Fargo & Company has the lowest price target set, forecasting a price of $70.00 for HealthEquity in the next year.
View the latest price targets for HQY.

What is the current consensus analyst rating for HealthEquity?

HealthEquity currently has 3 hold ratings, 6 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe HQY will outperform the market and that investors should add to their positions of HealthEquity.
View the latest ratings for HQY.

What other companies compete with HealthEquity?

How do I contact HealthEquity's investor relations team?

HealthEquity's physical mailing address is 15 WEST SCENIC POINTE DRIVE SUITE 100, DRAPER UT, 84020. The company's listed phone number is 801-727-1000 and its investor relations email address is [email protected] The official website for HealthEquity is www.healthequity.com.